STEMCELL Technologies’ Chief Innovation Officer, John Lilleyman, was featured on Constellation Research’s Business Transformation 150 (BT150) elite list of global business executives who have demonstrated transformative leadership efforts in their… Read More
Voclosporin ophthalmic solution (VOS) results anticipated in the fourth quarter of 2020 – VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage… Read More
Findings Support Commencement of VAL-083’s Participation in Pivotal GCAR GBM AGILE Study SAN DIEGO, June 22, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused… Read More
NL-201 demonstrates durable antitumor activity in animal tumor models – – NL-201 and targeted variants improve outcomes when combined with CAR-T cells in vivo – – Conditional activation of de novo… Read More
Vancouver, BC – June 19, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
